{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T06:25:23Z","timestamp":1792218323145,"version":"4.4.0"},"update-to":[{"DOI":"10.1002\/14651858.cd010756","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2015,4,24]],"date-time":"2015-04-24T00:00:00Z","timestamp":1429833600000}}],"reference-count":59,"publisher":"Wiley","issue":"1","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd010756.pub2","type":"journal-article","created":{"date-parts":[[2015,4,24]],"date-time":"2015-04-24T00:51:56Z","timestamp":1429836716000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Corticosteroids for the management of cancer-related pain in adults"],"prefix":"10.1002","volume":"2021","author":[{"given":"Alison","family":"Haywood","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Menzies Health Institute Queensland, Griffith University; Gold Coast Australia"},{"name":"Mater Research Institute - The University of Queensland; Brisbane Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillip","family":"Good","sequence":"additional","affiliation":[{"name":"Department of Palliative Care; St Vincent's Private Hospital; Brisbane Australia"},{"name":"Mater Research Institute - The University of Queensland; Brisbane Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sohil","family":"Khan","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Menzies Health Institute Queensland, Griffith University; Gold Coast Australia"},{"name":"Mater Research Institute - The University of Queensland; Brisbane Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurelia","family":"Leupp","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences; University of Basel; Basel Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sue","family":"Jenkins-Marsh","sequence":"additional","affiliation":[{"name":"The Townsville Hospital; Townsville Australia"},{"name":"Palliative Care; St Vincent\u2019s Private Hospital; Brisbane Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsty","family":"Rickett","sequence":"additional","affiliation":[{"name":"The University of Queensland Library; UQ\/Mater McAuley Library; Brisbane Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet R","family":"Hardy","sequence":"additional","affiliation":[{"name":"Mater Research Institute - The University of Queensland; Brisbane Australia"},{"name":"Department of Palliative and Supportive Care; Mater Health Services; Brisbane Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2015,4,24]]},"reference":[{"issue":"4","key":"10.1002\/14651858.CD010756.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s00256-011-1300-6","article-title":"Intrasomatic injection of corticosteroid followed by vertebroplasty increases early pain relief rather than vertebroplasty alone in vertebral bone neoplasms: preliminary experience","volume":"41","author":"Basile","year":"2012","journal-title":"Skeletal Radiology"},{"issue":"7-8","key":"10.1002\/14651858.CD010756.pub2-BIB0002|cit2","first-page":"751","article-title":"Action of oral methylprednisolone in terminal cancer patients: a prospective randomized double-blind study","volume":"69","author":"Bruera","year":"1985","journal-title":"Cancer Treatment Reports"},{"issue":"4","key":"10.1002\/14651858.CD010756.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.jpainsymman.2004.01.009","article-title":"Dexamethasone in addition to metoclopramide for chronic nausea in patients with advanced cancer: a randomized controlled trial","volume":"28","author":"Bruera","year":"2004","journal-title":"Journal of Pain and Symptom Management"},{"issue":"12","key":"10.1002\/14651858.CD010756.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1016\/0277-5379(89)90353-2","article-title":"Effect of methylprednisolone sodium succinate on quality of life in preterminal cancer patients: a placebo-controlled, multicenter study. The Methylprednisolone Preterminal Cancer Study Group","volume":"25","author":"Della Cuna","year":"1989","journal-title":"European Journal of Cancer & Clinical Oncology"},{"issue":"1","key":"10.1002\/14651858.CD010756.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1200\/JCO.2001.19.1.62","article-title":"Flutamide versus prednisone in patients with prostate cancer symptomatically progressing after androgen-ablative therapy: a phase III study of the European organization for research and treatment of cancer genitourinary group","volume":"19","author":"Fossa","year":"2001","journal-title":"Journal of Clinical Oncology"},{"issue":"1","key":"10.1002\/14651858.CD010756.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.clon.2005.08.015","article-title":"A pilot randomised comparison of dexamethasone 96 mg vs 16 mg per day for malignant spinal-cord compression treated by radiotherapy: TROG 01.05 Superdex study","volume":"18","author":"Graham","year":"2006","journal-title":"Clinical Oncology"},{"issue":"2","key":"10.1002\/14651858.CD010756.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/bjc.2012.593","article-title":"Epidural methadone results in dose-dependent analgesia in cancer pain, further enhanced by epidural dexamethasone","volume":"108","author":"Lauretti","year":"2013","journal-title":"British Journal of Cancer"},{"issue":"4","key":"10.1002\/14651858.CD010756.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/j.1365-2141.2008.07378.x","article-title":"Bortezomib is associated with better health-related quality of life than high-dose dexamethasone in patients with relapsed multiple myeloma: results from the APEX study","volume":"143","author":"Lee","year":"2008","journal-title":"British Journal of Haematology"},{"issue":"1","key":"10.1002\/14651858.CD010756.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1177\/1049909106295431","article-title":"A prospective randomized study of corticosteroids as adjuvant drugs to opioids in advanced cancer patients","volume":"24","author":"Mercadante","year":"2007","journal-title":"American Journal of Hospice and Palliative Medicine"},{"issue":"29","key":"10.1002\/14651858.CD010756.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.1200\/JCO.2013.54.3926","article-title":"Efficacy of methylprednisolone on pain, fatigue, and appetite loss in patients with advanced cancer using opioids: a randomized, placebo-controlled, double-blind trial","volume":"32","author":"Klepstad","year":"2014","journal-title":"Journal of Clinical Oncology"},{"issue":"12","key":"10.1002\/14651858.CD010756.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1016\/0277-5379(89)90354-4","article-title":"Methylprednisolone as palliative therapy for female terminal cancer patients. The Methylprednisolone Female Preterminal Cancer Study Group","volume":"25","author":"Popiela","year":"1989","journal-title":"European Journal of Cancer & Clinical Oncology"},{"issue":"4","key":"10.1002\/14651858.CD010756.pub2-BIB0012|cit12","first-page":"185","article-title":"Symptomatic relief for patients with osseous metastasis treated with radiation and methylpredonisolone: a prospective randomized study","volume":"14","author":"Teshima","year":"1996","journal-title":"Radiation Medicine - Medical Imaging and Radiation Oncology"},{"issue":"1399","key":"10.1002\/14651858.CD010756.pub2-BIB0013|cit13","first-page":"57","article-title":"Prednisolone in terminal breast and bronchogenic cancer","volume":"229","author":"Twycross","year":"1985","journal-title":"Practitioner"},{"issue":"9","key":"10.1002\/14651858.CD010756.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1212\/WNL.39.9.1255","article-title":"Initial bolus of conventional versus high-dose dexamethasone in metastatic spinal cord compression","volume":"39","author":"Vecht","year":"1989","journal-title":"Neurology"},{"issue":"25","key":"10.1002\/14651858.CD010756.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.1200\/JCO.2012.44.4661","article-title":"Reduction of cancer-related fatigue with dexamethasone: a double-blind, randomized, placebo-controlled trial in patients with advanced cancer","volume":"31","author":"Yennurajalingam","year":"2013","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD010756.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/0022-4731(83)91775-2","article-title":"Comparison of 6-methylprednisolone (6-MP) and placebo in improvement of the quality of life in pre-terminal cancer patients [abstract]","volume":"19 Suppl","author":"Campio","year":"1983","journal-title":"Journal of Steroid Biochemistry"},{"issue":"10","key":"10.1002\/14651858.CD010756.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1002\/cncr.25748","article-title":"Tumor flare reaction associated with lenalidomide treatment in patients with chronic lymphocytic leukaemia predicts clinical response","volume":"117","author":"Chanan-Khan","year":"2011","journal-title":"Cancer"},{"issue":"1","key":"10.1002\/14651858.CD010756.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/00000539-200101000-00017","article-title":"Dexamethasone facilitates discharge after outpatient anorectal surgery","volume":"92","author":"Coloma","year":"2001","journal-title":"Anesthesia and Analgesia"},{"issue":"1","key":"10.1002\/14651858.CD010756.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/00005392-199707000-00056","article-title":"Is prednisolone as good as flutamide in hormone refractory metastatic carcinoma of the prostate?","volume":"158","author":"Datta","year":"1997","journal-title":"Journal of Urology"},{"key":"10.1002\/14651858.CD010756.pub2-BIB0020|cit20","first-page":"175","article-title":"Topical mometasone furoate (0.1%)-An effective prophylaxis for prevention of radiation dermatitis: A prospective randomized study","volume":"8","author":"Dutta","year":"2012","journal-title":"Journal of Cancer Research and Therapeutics"},{"issue":"3","key":"10.1002\/14651858.CD010756.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/ajh.2830360303","article-title":"High-dose dexamethasone for refractory or relapsing multiple myeloma","volume":"36","author":"Friedenberg","year":"1991","journal-title":"American Journal of Hematology"},{"issue":"6","key":"10.1002\/14651858.CD010756.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1111\/j.1365-2036.2011.04780.x","article-title":"Randomised clinical trial: preventive treatment with topical rectal beclomethasone dipropionate reduces post-radiation risk of bleeding in patients irradiated for prostate cancer","volume":"34","author":"Fuccio","year":"2011","journal-title":"Alimentary Pharmacology & Therapeutics"},{"key":"10.1002\/14651858.CD010756.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1186\/1471-2407-10-692","article-title":"Preoperative dexamethasone reduces postoperative pain, nausea and vomiting following mastectomy for breast cancer","volume":"10","author":"Gomez-Hernandez","year":"2010","journal-title":"BMC Cancer"},{"issue":"4","key":"10.1002\/14651858.CD010756.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.clon.2008.12.010","article-title":"Dexamethasone for the prophylaxis of radiation-induced pain flare after palliative radiotherapy for symptomatic bone metastases: a phase II study","volume":"21","author":"Hird","year":"2009","journal-title":"Clinical Oncology (Royal College of Radiologists)"},{"issue":"1","key":"10.1002\/14651858.CD010756.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1191\/026921600669298725","article-title":"The use of steroids in the management of inoperable intestinal obstruction in terminal cancer patients: do they remove the obstruction?","volume":"14","author":"Laval","year":"2000","journal-title":"Palliative Medicine"},{"issue":"3","key":"10.1002\/14651858.CD010756.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1378\/chest.123.3.822","article-title":"A randomized, phase III, double-blind, placebo-controlled trial of intrapleural instillation of methylprednisolone acetate in the management of malignant pleural effusion","volume":"123","author":"North","year":"2003","journal-title":"Chest"},{"issue":"34","key":"10.1002\/14651858.CD010756.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"5713","DOI":"10.1200\/JCO.2009.22.2679","article-title":"Multicenter, phase I, dose-escalation trial of lenalidomide plus bortezomib for relapsed and relapsed\/refractory multiple myeloma","volume":"27","author":"Richardson","year":"2009","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD010756.pub2-BIB0028|cit28","first-page":"Abstract 864","article-title":"A Phase 1\/2 multi-center, randomized, open label dose escalation study to determine the maximum tolerated dose, safety, and efficacy of pomalidomide alone or in combination with low-dose dexamethasone in patients with relapsed and refractory multiple myeloma who have received prior treatment that includes lenalidomide and bortezomib","volume":"116","author":"Richardson","year":"2010","journal-title":"Blood, ASH Annual Meeting Abstracts"},{"key":"10.1002\/14651858.CD010756.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"Abstract 634","DOI":"10.1182\/blood.V118.21.634.634","article-title":"Randomized, open label phase 1\/2 study of pomalidomide (POM) alone or in combination with low-Dose Dexamethasone (LoDex) in patients (Pts) with relapsed and refractory multiple myeloma who have received prior treatment that includes lenalidomide (LEN) and bortezomib (BORT): Phase 2 results","volume":"118","author":"Richardson","year":"2011","journal-title":"Blood"},{"key":"10.1002\/14651858.CD010756.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"Abstract 4053","DOI":"10.1182\/blood.V120.21.4053.4053","article-title":"Treatment outcomes with pomalidomide (POM) in combination with low-dose dexamethasone (LODEX) in patients with relapsed and refractory multiple myeloma (RRMM) and del(17p13) and\/or t(4;14)(p16;q32) cytogenetic abnormalities who have received prior therapy with lenalidomide (LEN) and bortezomib (BORT)","volume":"120","author":"Richardson","year":"2012","journal-title":"Blood"},{"issue":"15","key":"10.1002\/14651858.CD010756.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"9150","DOI":"10.1200\/jco.2010.28.15_suppl.9150","article-title":"Randomized phase II trial of carboplatin (C) and gemcitabine (G) with or without dexamethasone (Dex) in patients (pts) with stage IV non-small cell lung cancer (NSCLC)","volume":"28","author":"Rinehart","year":"2010","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD010756.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S1090-3801(09)60915-0","article-title":"The combination of epidural methadone and dexamethasone for cancer pain","volume":"13","author":"Rizzo","year":"2009","journal-title":"European Journal of Pain"},{"issue":"7","key":"10.1002\/14651858.CD010756.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1007\/s00066-003-1082-4","article-title":"Sucralfate versus mesalazine versus hydrocortisone in the prevention of acute radiation proctitis during conformal radiotherapy for prostate carcinoma. A randomized study","volume":"179","author":"Sanguineti","year":"2003","journal-title":"Strahlentherapie und Onkologie"},{"issue":"6","key":"10.1002\/14651858.CD010756.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1046\/j.1365-2133.2002.04751.x","article-title":"Topical corticosteroid therapy for acute radiation dermatitis: a prospective, randomized, double-blind study","volume":"146","author":"Schmuth","year":"2002","journal-title":"British Journal of Dermatology"},{"issue":"1","key":"10.1002\/14651858.CD010756.pub2-BIB0035|cit35","first-page":"75","article-title":"Effect of dexamethasone addition to epidural morphine on pain, and morphine-related side effects after pelvic oncologic surgery","volume":"24","author":"Tantawy","year":"2008","journal-title":"Egyptian Journal of Anaesthesia"},{"issue":"5","key":"10.1002\/14651858.CD010756.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1002\/1097-0142(19820901)50:5<893::AID-CNCR2820500515>3.0.CO;2-Y","article-title":"The palliation of symptomatic osseous metastases. Final results of the study by the Radiation Therapy Oncology Group","volume":"50","author":"Tong","year":"1982","journal-title":"Cancer"},{"issue":"4","key":"10.1002\/14651858.CD010756.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1212\/WNL.44.4.675","article-title":"Dose-effect relationship of dexamethasone on Karnofsky performance in metastatic brain tumors: a randomized study of doses of 4, 8, and 16 mg per day","volume":"44","author":"Vecht","year":"1994","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD010756.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"Abstract: 4070","DOI":"10.1182\/blood.V120.21.4070.4070","article-title":"Pomalidomide (POM) with low-dose dexamethasone (LODEX) in patients with relapsed and refractory multiple myeloma (RRMM): Outcomes based on prior treatment exposure","volume":"120","author":"Vij","year":"2012","journal-title":"Blood"},{"issue":"15s","key":"10.1002\/14651858.CD010756.pub2-BIB0039|cit39","first-page":"Abstract: TPS31","article-title":"The effect of dexamethasone on symptom burden in patients with advanced cancer","volume":"28","author":"Yennurajalingam","year":"2010","journal-title":"Journal of Clinical Oncology"},{"issue":"Suppl","key":"10.1002\/14651858.CD010756.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"Abstract 9002","DOI":"10.1200\/jco.2012.30.15_suppl.9002","article-title":"Dexamethasone (DM) for cancer-related fatigue: A double-blinded, randomized, placebo-controlled trial","volume":"30","author":"Yennurajalingam","year":"2012","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD010756.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S0959-8049(11)72420-0","article-title":"Randomized phase II trial of gemcitabine and carboplatin (G\/C) with or without dexamethasone (DEX) pretreatment in chemotherapy-naive patients (pts) with advanced non-small cell lung cancer (NSCLC) - Results of kyoto thoracic oncology research group (KTORG) trial 0501","volume":"47","author":"Yoshioka","year":"2011","journal-title":"European Journal of Cancer"},{"issue":"3","key":"10.1002\/14651858.CD010756.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.tem.2012.11.005","article-title":"The five Rs of glucocorticoid action during inflammation: ready, reinforce, repress, resolve, and restore","volume":"24","author":"Busillo","year":"2013","journal-title":"Trends in Endocrinology and Metabolism"},{"key":"10.1002\/14651858.CD010756.pub2-BIB0043|cit43","volume-title":"Therapeutic Guidelines: eTG Complete [electronic resource]","year":"2014"},{"key":"10.1002\/14651858.CD010756.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1177\/104990919000700107","article-title":"The use of corticosteroids for symptom management in terminally ill patients","volume":"7","author":"Farr","year":"1990","journal-title":"American Journal of Hospice and Palliative Care"},{"issue":"5","key":"10.1002\/14651858.CD010756.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1177\/0269216311400480","article-title":"How well is cancer pain treated?","volume":"25","author":"Foley","year":"2011","journal-title":"Palliative Medicine"},{"issue":"3","key":"10.1002\/14651858.CD010756.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/S0885-3924(02)00487-6","article-title":"A retrospective observation of corticosteroid use at the end of life in a hospice","volume":"24","author":"Gannon","year":"2002","journal-title":"Journal of Pain and Symptom Management"},{"key":"10.1002\/14651858.CD010756.pub2-BIB0047|cit47","doi-asserted-by":"crossref","DOI":"10.1093\/med\/9780198570295.001.0001","volume-title":"Oxford Textbook of Palliative Care","author":"Hanks","year":"2009"},{"key":"10.1002\/14651858.CD010756.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1191\/026921601673324846","article-title":"A prospective survey of the use of dexamethasone on a palliative care unit","volume":"15","author":"Hardy","year":"2001","journal-title":"Palliative Medicine"},{"key":"10.1002\/14651858.CD010756.pub2-BIB0049|cit49","unstructured":"Higgins JPT Chapter 8: Assessing risk of bias in included studies In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD010756.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/2046-4053-2-81","article-title":"Assessing and presenting summaries of evidence in Cochrane Reviews","volume":"2","author":"Langendam","year":"2013","journal-title":"Systematic Reviews"},{"key":"10.1002\/14651858.CD010756.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s11916-012-0273-z","article-title":"The role of corticosteroids in the treatment of pain in cancer patients","volume":"16","author":"Leppert","year":"2012","journal-title":"Current Pain and Headache Reports"},{"issue":"4","key":"10.1002\/14651858.CD010756.pub2-BIB0052|cit52","doi-asserted-by":"publisher","first-page":"W65","DOI":"10.7326\/0003-4819-151-4-200908180-00136","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"151","author":"Liberati","year":"2009","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD010756.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jpainsymman.2012.06.019","article-title":"Do corticosteroids provide analgesic effects in cancer patients? A systematic review","volume":"46","author":"Paulsen","year":"2013","journal-title":"Journal of Pain and Symptom Management"},{"issue":"11 Suppl 5","key":"10.1002\/14651858.CD010756.pub2-BIB0054|cit54","first-page":"S21","article-title":"Pharmacologic management of cancer pain","volume":"105","author":"Pharo","year":"2005","journal-title":"Journal of the American Osteopathic Association"},{"key":"10.1002\/14651858.CD010756.pub2-BIB0055|cit55","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2014"},{"issue":"12","key":"10.1002\/14651858.CD010756.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1007\/s00520-007-0253-8","article-title":"Symptom and medication profiles among cancer patients attending a palliative care clinic","volume":"15","author":"Riechelmann","year":"2007","journal-title":"Supportive Care in Cancer"},{"key":"10.1002\/14651858.CD010756.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/annonc\/mdm056","article-title":"Prevalence of pain in patients with cancer: a systematic review of the past 40 years","volume":"18","author":"Van den Beuken-van Everdingen","year":"2007","journal-title":"Annals of Oncology"},{"issue":"12","key":"10.1002\/14651858.CD010756.pub2-BIB0058|cit58","first-page":"1295","article-title":"Steroids as pain relief adjuvants","volume":"56","author":"Vyvey","year":"2010","journal-title":"Canadian Family Physician"},{"issue":"10","key":"10.1002\/14651858.CD010756.pub2-BIB0059|cit59","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010756","article-title":"Corticosteroids for the management of cancer-related pain in adults","author":"Hardy","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD010756.pub2\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,8]],"date-time":"2024-06-08T11:47:08Z","timestamp":1717847228000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD010756.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Pain, Palliative and Supportive Care Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,4,24]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,1]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd010756.pub2","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.725448685.793506527","asserted-by":"object"}]},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,24]]}}}